GH Research Plc (GHRS)
15.70
-0.10
(-0.63%)
USD |
NASDAQ |
Feb 20, 15:46
GH Research EPS Diluted (Quarterly) : -0.226 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.3701 |
| Jazz Pharmaceuticals Plc | 4.081 |
| Prothena Corp. Plc | -0.6788 |
| Iterum Therapeutics Plc | -0.196 |
| Cosmo Pharmaceuticals NV | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.02M |
| Total Expenses (Quarterly) | 14.02M |
| Enterprise Value | 692.14M |
| Earnings Yield | -4.66% |
| Normalized Earnings Yield | -5.218 |